Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Department of Cell Biology and Physiology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Methods Mol Biol. 2021;2270:125-147. doi: 10.1007/978-1-0716-1237-8_8.
Emerging research suggests that IL-35-producing regulatory B cells accumulate in patients and mouse models of pancreatic cancer, one of the most lethal cancers, characterized by late diagnosis, high mortality, and morbidity. Identification of IL-35-producing B cells can be challenging due to the heterodimeric nature of IL-35 and diversity of cell surface markers that define regulatory B-cell subsets across spectrum of diseases. In this chapter, we describe the methods for the isolation of splenic and tumor-infiltrating murine regulatory B cells and subsequent detection of IL-35 by RT-qPCR and intracellular staining, as well as detection of circulating IL-35 by ELISA. We also describe methods for the detection of IL-35-producing human B cells by flow cytometry, RT-qPCR, and immunofluorescence in the context of pancreatic cancer. This chapter should facilitate the study of regulatory IL-35 B cells in cancer, autoimmunity, and inflammation.
新兴研究表明,IL-35 产生的调节性 B 细胞在胰腺癌患者和小鼠模型中积累,胰腺癌是最致命的癌症之一,其特征为诊断较晚、死亡率和发病率高。由于 IL-35 的异二聚体性质以及在疾病谱中定义调节性 B 细胞亚群的细胞表面标志物的多样性,IL-35 产生的 B 细胞的鉴定具有一定挑战性。在本章中,我们描述了分离脾和肿瘤浸润性小鼠调节性 B 细胞的方法,以及通过 RT-qPCR 和细胞内染色检测 IL-35 的方法,以及通过 ELISA 检测循环中的 IL-35 的方法。我们还描述了在胰腺癌背景下通过流式细胞术、RT-qPCR 和免疫荧光检测 IL-35 产生的人类 B 细胞的方法。本章应有助于研究癌症、自身免疫和炎症中的调节性 IL-35 B 细胞。